Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHA:605033)
China
· Delayed Price · Currency is CNY 23.29
+0.39 (1.70%)
Mar 10, 2026, 1:35 PM CST
SHA:605033 Revenue
Shaanxi Meibang Pharmaceutical Group had revenue of 123.56M CNY in the quarter ending September 30, 2025, with 9.17% growth. This brings the company's revenue in the last twelve months to 871.63M, up 13.47% year-over-year. In the year 2024, Shaanxi Meibang Pharmaceutical Group had annual revenue of 885.53M with 26.68% growth.
Revenue (ttm)
871.63M
Revenue Growth
+13.47%
P/S Ratio
3.55
Revenue / Employee
873.38K
Employees
998
Market Cap
3.10B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Liuzhou Chemical Industry | 148.27M |
| Jiangsu Huifeng Bio Agriculture | 345.58M |
| Zhejiang XinNong Chemical | 1.04B |
| Beihai Gofar Chuanshan Biological | 316.06M |
| Yingde Greatchem Chemicals | 788.99M |
| Jiangsu Flag Chemical Industry | 2.52B |
| Jiangsu Fengshan Group Co.,Ltd | 1.16B |
| Hubei Forbon Technology | 1.32B |